Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 6 250 KRW -0.64% Market Closed
Market Cap: 174.6B KRW

Wall Street
Price Targets

Price Targets Summary
Dongwha Pharm Co Ltd

There are no price targets for Dongwha Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Dongwha Pharm Co Ltd Competitors:
Price Targets
1177
Sino Biopharmaceutical Ltd
54% Upside
AUROPHARMA
Aurobindo Pharma Ltd
14% Upside
1681
Consun Pharmaceutical Group Ltd
24% Upside
ORX
Orexo AB
13% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
DPHARMA
Duopharma Biotech Bhd
38% Upside
6996
Antengene Corporation Ltd
96% Upside
000100
Yuhan Corp
27% Upside

Revenue
Forecast

Revenue Estimate
Dongwha Pharm Co Ltd

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 1 year is -5%.

5%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dongwha Pharm Co Ltd

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's operating income is -3%. The projected CAGR for the next 1 year is 238%.

-3%
Past Growth
238%
Estimated Growth
Estimates Accuracy
-54%
Average Miss

Net Income
Forecast

Net Income Estimate
Dongwha Pharm Co Ltd

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's net income is -9%. The projected CAGR for the next 1 year is 605%.

-9%
Past Growth
605%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongwha Pharm Co Ltd's stock price target?
Not Available

Dongwha Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Dongwha Pharm Co Ltd's Revenue forecast?
Projected CAGR
-5%

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 1 year is -5%.

What is Dongwha Pharm Co Ltd's Operating Income forecast?
Projected CAGR
238%

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's operating income is -3%. The projected CAGR for the next 1 year is 238%.

What is Dongwha Pharm Co Ltd's Net Income forecast?
Projected CAGR
605%

For the last 13 years the compound annual growth rate for Dongwha Pharm Co Ltd's net income is -9%. The projected CAGR for the next 1 year is 605%.

Back to Top